Search

Haya M Almalag,1 Lobna Al Juffali,1 Maha M Alshehri,2 Nouf A Altokhais,2 Ghada A Aljanobi,3 Maha I El Dessougi,4 Amal AlHarthi,4 Suzan M Attar,5 Sami M Bahlas,5 Abdullah S Alfurayj,6 Mansour S Alazmi,7 Alhussain M Asiri,8 Mohammed M AlOmair,8 Mohammed A Omair9 1Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 3Rheumatology Unit, Department of Medicine, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; 4Rheumatology Unit, Department of Medicine, Security Forces Hospital, Riyadh, Saudi Arabia; 5Rheumatology Unit, Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 6Rheumatology Unit, Department of Medicine, Buraidah Central Hospital, Buraidah, Saudi Arabia; 7Rheumatology Unit, Department of Medicine, Prince Mohammed Medical City, Sakaka-Aljouf, Saudi Arabia; 8Rheumatology Unit, Department of Medicine, Aseer Central Hospital, Abha, Saudi Arabia; 9Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Haya M Almalag, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, Email halmalaq@ksu.edu.saIntroduction: Multidisciplinary setting in healthcare provide positive patient outcomes.Objective: To evaluate the impact of specialized rheumatology clinics (multidisciplinary settings) on the activation and engagement of rheumatoid arthritis (RA) patients.Material and Methods: This cross-sectional survey assessed patient activation using the patient activation measure-13. Participants attending Specialized Rheumatology Clinics (SRC multidisciplinary clinics) were compared with age- and sex-matched patients attending Standard of Care (SOC). The study was observational in nature, assessing several demographic and therapeutic options and their relation to the clinical setting and patient activation.Results: This study included 117 SRC matched RA patient

Mohammed A Omair,1 Maha M Alshehri,2 Nouf A Altokhais,2 Ghada A Aljanobi,3 Maha I El Dessougi,4 Amal AlHarthi,4 Maha A Omair,5 Suzan M Attar,6 Sami M Bahlas,6 Abdullah S Alfurayj,7 Mansour S Alazmi,8 Alhussain M Asiri,9 Mohammed M AlOmair,9 Lobna Al Juffali,10 Haya M Almalag10 1Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia; 2College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 3Rheumatology Unit, Department of Medicine, Qatif Central Hospital, Qatif, Saudi Arabia; 4Rheumatology Unit, Department of Medicine, Security Forces Hospital, Riyadh, Saudi Arabia; 5Department of Statistics and Operations Research, College of Science, King Saud University, Riyadh, Saudi Arabia; 6Rheumatology Unit, Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; 7Rheumatology Unit, Department of Medicine, Buraidah Central Hospital, Buraidah, Saudi Arabia; 8Rheumatology Unit, Department of Medicine, Prince Mohammed Medical City, Sakaka-Aljouf, Saudi Arabia; 9Rheumatology Unit, Department of Medicine, Aseer Central Hospital, Abha, Saudi Arabia; 10Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Mohammed A Omair, Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia, Tel +966505270513, Email momair@ksu.edu.saPurpose: Compliance is essential to achieve treatment goals in rheumatoid arthritis (RA) patients. The current study evaluated compliance and related factors in a large and diverse population.Patients and Methods: Patients with RA who received active treatment were invited to participate in an online survey. The Arabic versions of the 5-Item Compliance Questionnaire for Rheumatology (ACQR-5) and the RA Impact of Disease (RAID) were used to measure compliance and disability, respectively. The patients were sub-grouped based on background disease-modifying anti-rheumatic drugs (DMARDs). Variables associated with high complianc

Hussain Issa1, Sami Al-Momen1, Bahaa Bseiso1, Ghada Ali Al-Janobi1, Mohamad A Aljama1, Fadel Ali Almousa1, Mahdi E Al-Jarodi1, Ahmed H Al-Salem21Department of Internal Medicine, King Fahad Specialist Hospital, Dammam, Saudi Arabia; 2Department of Pediatric Surgery, Maternity and Children Hospital, Dammam, Saudi ArabiaAbstract: Thromboembolism (TE) is a serious but under-recognized complication of inflammatory bowel disease (IBD). This is specially so in developing countries where the incidence of IBD is low. In Saudi Arabia, IBD is considered to be rare, but the incidence is increasing. Where the clinical manifestations resemble those of developed countries, TE as a complication of IBD is considered to be very rare. This report describes six IBD patients with TE. This importance of the complication of TE is stressed, and physicians caring for these patients should be aware of it in order to obviate potential morbidity and mortality.Keywords: thromboembolism, inflammatory bowel disease, Crohn's disease, ulcerative colitis